TMBR
Timber Pharmaceuticals, Inc.
TMBR
TMBR
Delisted
TMBR was delisted on the 28th of November, 2023.
13 hedge funds and large institutions have $595K invested in Timber Pharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$19.2K | |
| 2 | +$15.9K | |
| 3 | +$13.4K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$11.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.5K |
Top Sellers
| 1 | -$271K | |
| 2 | -$46K | |
| 3 | -$19K | |
| 4 |
Two Sigma Investments
New York
|
-$17K |